Saxon COVID-19 research consortium of non-university, university and clinical partners – joint project

Funded by the Free State of Saxony, the SaxoCOV project consortium was established on September 1, 2020. Under the leadership of the Fraunhofer Institute for Cell Therapy and Immunology, six non-university, university and clinical partners from Saxony are involved. IZBI also participate in the project.

The consortium is conducting a Saxony-wide field study on the spread of SARS-CoV-2. It is supported by two other non-Saxon research institutions. The aim is to create a scientific tool to follow the development of the SARS-CoV-2 epidemic in the Free State of Saxony on multiple levels. On the one hand, the field study will serve to monitor the effectiveness of governmental measures to contain the pandemic, and on the other hand, it will support the detection and containment of outbreak scenarios. The informed knowledge base thus created will enable predictions of future developments and help assess the effectiveness of containment measures.

The samples and data collected will also be used in a companion research study to answer further research questions. In particular, the question of which causes are responsible for the very different mild or aggressive course of the disease and whether there are parameters that can be used to predict these different courses is pressing.

project leader at IZBI Prof. Dr. Markus Löffler

duration 01.09.2020 – 31.12.2022

joint project / third-party founding

project partner

  • Medizinische Fakultät, Universität Leipzig |  
  • Helmholtz-Zentrum für Umweltforschung GmbH – UFZ, Leipzig |  
  • Max-Planck-Institut für Molekulare Zellbiologie und Genetik, Dresden |
  • Medizinische Fakultät, TU Dresden |
  • Städtisches Krankenhaus Sankt Georg, Leipzig |

Extern Partner Field Study

Wrocław University of Science and Technology, Wrocław, Polen |  

Universität Münster, Institut für Epidemiologie und Sozialmedizin |

Further information will follow shortly on a separate website on the SaxoCOV project.